Philip Tsai

Insider Reports History

Location
Bothell, WA
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip Tsai:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immunome Inc. Chief Technical Officer Common Stock 43,300 $887,216 $20.49 19 Dec 2025 Direct
Immunome Inc. Chief Technical Officer Employee Stock Option (right to buy) 190,000 29 Jul 2025 Direct

Insider Reports Filed by Philip Tsai

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMNM Immunome Inc. 19 Dec 2025 1 +$204,900 4 Chief Technical Officer 22 Dec 2025, 07:32
IMNM Immunome Inc. 29 Jul 2025 1 $0 4 Chief Technical Officer 31 Jul 2025, 19:00
IMNM Immunome Inc. 24 Mar 2025 1 +$103,566 4 Chief Technology Officer 25 Mar 2025, 17:15
IMNM Immunome Inc. 21 Nov 2024 1 +$198,030 4 Chief Technology Officer 25 Nov 2024, 08:33
IMNM Immunome Inc. 17 Jun 2024 1 $0 4 Chief Technology Officer 18 Jun 2024, 21:08
IMNM Immunome Inc. 17 Jun 2024 0 $0 3 Chief Technology Officer 18 Jun 2024, 21:05
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .